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Abstract. In this article the calculations of the activation free energy for a chemical reaction between sty-
rene-7,8-oxide and DNA, in particular guanine at position N7, are reported. Calculations were performed 
by Hartree-Fock and DFT methods in conjunction with flexible basis sets. Effects of solvation were con-
sidered using the Langevin dipoles method. The calculated activation free energies are in good agreement 
with the experimental value of 26.52 kcal mol−1. 
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INTRODUCTION 
Carcinogenesis is a complex pathological process, 
where normal cells become neoplastic. Mainly is the 
process associated with chemical modification of 
DNA. Chemical reactions of DNA are associated with 
viruses, photochemical processes and reactive chemi-
cals.1,2,3,4 If the chemicals are hormones or their meta-
bolites, then they can be referred either as endogen-
ous5,6 or exogenous carcinogens.7 If they come from 
the environment they are referred to as exogenous 
carcinogens. 
Styrene is widely used in the chemical industry 
in particular in the production of unsaturated polyest-
ers and polystyrene. Having entered the human body 
either via respiration or absorption through skin, sty-
rene is metabolized into styrene-7,8-oxide primarily in 
the liver and to a lesser extent in kidney, intestine and 
lung. The main metabolic pathway for styrene is oxi-
dation mainly via CYP 2E1 a member of cytochrome 
P450 mixed-function oxydase system (to styrene-7,8-
oxide (STO), followed by rapid enzymatic hydration to 
styrene glycol or conjugation with glutathione. The 
styrene glycol is oxidized to mandelic acid, which is 
excreted in the urine. Further oxidation of mandelic 
acid also occurs, resulting in phenylglyoxylic acid, 
which is also excreted in the urine. For very recent and 
often updated information concerning the metabolism 
of styrene see the web page.8 
STO is a colorless to light yellowish liquid. It is un-
stable and it polymerizes with compounds like acids and 
alcohols. STO is a direct alkylating agent, which can 
react with nucleophilic sites in DNA in particular with 
guanine at position N7. Therefore, it can be mutagenic, 
cytotoxic and carcinogenic.9,10 Alkylation is followed by 
other reactions, of which depurination is a typical exam-
ple. At this point it is worth to emphasize that both epoxi-
dation and depurination are fast relative to DNA alkyla-
tion that represents the rate limiting step. Simultaneously 
STO degradation takes place by its hydrolysis to styrene 
glycol and its reaction with glutathione.8 
STO has been detected in blood of workers exposed 
to styrene in the reinforced plastics industry, whose bio-
materials showed also genotoxic effect induced by STO 
(e.g. adducts in hemoglobin and DNA, DNA single 
strand breaks/alkali labile sites) as reviewed by Hender-
son and Speit.11 Positive genotoxic results were asso-
ciated with higher overall STO levels and negative results 
with decreasing exposures to styrene, but several epide-
miologic studies could not confirm a correlation between 
styrene exposure and increased incidence of cancer in 
human.12−15 On a contrary, STO was found to be carcino-
genic in rats and mice. If rats and mice receive styrene by 
oral gavage16 or inhalation,17 they develop benign and 
malignant tumors of breast and forestomach.18 In addi-
tion, a higher incidence of hepatocellular tumors was 
found in male mice.18 
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So, there is inadequate evidence in human for the 
carcinogenicity of STO, whereas there is sufficient 
evidence for the carcinogenicity of STO in experimental 
animals. Overall evaluation: styrene is classified as a 
possible carcinogenic compound according to Interna-
tional Agency for Research on Cancer classification 
(IARC) – group 2B, whereas its main metabolite sty-
rene-7,8-oxide is classified as probably carcinogenic to 
humans (IARC – group 2A).19 
As previously mentioned, the N7 of guanine is the 
major site of STO alkylation. It is well established that 
the rate limiting step for reaction of the ultimate carci-
nogens of the epoxy type with the nucleophilic sites of 
DNA and proteins is the epoxide ring opening.20 The 
intermediate picks up the proton from the protein rich 
aqueous environment and this step is believed to be 
fast.21 
The kinetics of guanine alkylation was studied ex-
perimentally,22 and from the rate constant determined 
free energy of activation was 26.52 kcal mol−1. The free 
energy of activation was calculated from the rate con-
stant using the transition state formula. 
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   (1) 
In the above equation kB represents Boltzmann 
constant, h Planck constant, and T the absolute tempera-
ture. Transition state theory is based on the assumption 
that reactants and transition states form a thermal equi-
librium. The reaction rate constant has been determined 
in a whole blood solution. HPLC in conjunction with 
UV spectroscopy was used to measure the time-
dependent concentrations of adducts. Realistic simula-
tion of chemical reactivity of nucleic acids in aqueous 
solution is a challenge for computational chemistry. 
Schrader and Linscheid demonstrated that in addition to 
N7 guanine adduct STO forms adduct also with O6 and 
N2 of guanine and nucleophilic sites of adenine.10 It 
remains a major challenge to model those reactions in 
particular the factors controlling the selectivity. 
In this study, we calculated activation free energy 
for alkylation of guanine by styrene-7,8-oxide and com-
pared it to the experimental free energy of activation. 
We applied Hartree-Fock and DFT methodology in 
conjunction with flexible basis sets. The effects of sol-
vation were included by using Langevin dipoles method 
of Florian and Warshel.23 
The organization of this article is as follows. The 
applied computational methods are described in section 




For calculation of the Born-Oppenheimer hypersurface 
and consequently the rate constant for the reaction be-
tween STO and guanine, we performed ab initio Hart-
ree-Fock and DFT calculations. The distance between 
the β-carbon atom of the STO linked to N7 of guanine 
was chosen to be the reaction coordinate. We optimized 
all degrees of freedom except the fixed value of the 
reaction coordinate for each calculation; the highest 
energy point on this path represents the approximation 
of the transition state. For the reactants a full geometry 
optimization was performed. The transition state struc-
ture was refined by the methodology built in Gaussian-
03.24 For optimization of the transition state the key-
words opt=(ts,noeigentest,calcfc) were used. Geome-
tries and atomic charges for reactants and transition 
states can be obtained from us on request. The differ-
ence between energy of the transition state and the reac-
tants is activation energy. For reactants and transition 
state we performed vibrational analysis in the harmonic 
approximation. For reactants all frequencies were real, 
while the transition state had one imaginary frequency 
predicted by all levels of theory. 
Calculation of the Born-Oppenheimer surface for 
chemical reactions is not a trivial task. It is generally 
believed that one needs relatively flexible basis sets and 
inclusion of electron correlation. Our calculations were 
performed on the Hartree-Fock level in conjunction 
with the following basis sets 6-31G(d), 6-31+G(d,p) and 
6-311++G(d,p). Calculations beyond the Hartree-Fock 
level (e.g. MP2) were not possible because of large size 
of the system. Therefore we considered the DFT method 
B3LYP that has exchange functional introduced by 
Becke25 and correlation functional introduced by Lee, 
Yang and Parr26 in conjunction with the same basis set. 
In addition, we applied the semiempirical MO method 
PM3. The latter method we applied because of its low 
CPU cost, which allows for QM/MM applications and 
thermal averaging. We are aware that DFT methods 
Scheme 1. Guanine alkylation by styrene-7,8-oxide. R stands
for the rest of DNA that was in our calculations truncated to
methyl group. 
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have also significant empirical character, nevertheless 
they include to some extent electron correlation. 
Free energy of hydration for reactants and transi-
tion state was calculated using Langevin dipoles (LD) 
method parameterized by Florian and Warshel.23 For LD 
calculations, Merz-Kollman atomic charges were de-
termined for each level of theory. Ab initio and semiem-
pirical MO calculations were performed by Gaussian-03 
suite of programs,24 while the LD calculations were 
obtained using the LD program ChemSol 2.1.23 Calcula-
tions were performed on a cluster of Linux workstations 
with Intel Pentium 2 GHz processors. We estimated that 
about 50 days of single processor CPU time was used. 
 
RESULTS 
The calculated activation energies, zero point energies 
and data for imaginary frequencies are collected in Ta-
ble 1. Langevin dipoles calculated free energies of hy-
dration are collected in Table 2 that includes also calcu-
lated free energy of activation. 
From Table 1 it is evident that for Hartree-Fock 
calculations of the barrier height we achieved conver-
gence in terms of the basis set size. It looks like that 
addition of diffuse function on heavy atoms and polari-
zation functions on both heavy atoms and hydrogens is 
crucial for prediction of the reaction barrier. The pre-
dicted Hartree-Fock level barriers are between 46.10 
and 48.73 kcal mol−1. 
Application of DFT significantly reduces the bar-
rier. Again the barrier does not change anymore with 
addition of basis functions when polarization functions 
are used on heavy atoms and hydrogens, while diffuse 
functions are only on heavy atoms. 
Semiempirical MO method PM3 yield the barrier 
comparable to HF level and seems to promising for 
QM/MM calculations that require thermal averaging. 






























HF/6-31G(d) 48.73 192.30 192.58 −0.28 568 
HF/6-31+G(d,p) 46.10 191.14 191.46 −0.32 562 
HF/6-311++G(d,p) 46.11 191.14 191.45 −0.31 562 
B3LYP/6-31G(d) 36.20 178.47 178.75 −0.28 468 
B3LYP/6-31+G(d,p) 33.86 177.62 177.88 −0.26 447 
B3LYP/6-311++G(d,p) 33.83 177.61 177.89 −0.28 447 
PM3 49.07 173.08 174.08 −1.00 727 
(a) Classical activation energy. 
(b) Zero point vibrational energy for the transition state. 
(c) Zero point vibrational energy for the reactants. 
(d) Zero point energy of the transition state minus zero point energy of the reactants. 
(e) Imaginary frequency value corresponding to the transition state. 


































HF/6-31G(d) −40.25 −22.84 −17.41 31.04 
HF/6-31+G(d,p) −41.84 −23.63 −18.21 27.57 
HF/6-311++G(d,p) −41.71 −23.56 −18.15 27.65 
B3LYP/6-31G(d) −31.79 −20.14 −11.65 24.27 
B3LYP/6-31+G(d,p) −35.99 −21.44 −14.55 19.05 
B3LYP/6-311++G(d,p) −35.84 −21.41 −14.43 19.12 
(a) Free energy of hydration for the transition state. 
(b) Free energy of hydration for the reactants. 
(c) Free energy of hydration of the transition state minus free energy of hydration of the reactants. 
(d) Free energy of activation obtained by Langevin dipoles method. Zero point correction is considered. 
    ∆G #(experimental) = 26.52 kcal mol−1, kr  = 1.97 × 10
−7 mol−1 s −1. 
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It was demonstrated that the PM3 method per-
forms well for energetics associated with the reaction 
catalyzed by xylose isomerase.27 Table 1 also shows that 
the zero point vibrational energy correction of the reac-
tion barrier is almost negligible. In addition, one can see 
from the Table 1, that the DFT calculated BO surfaces 
are shallower than the HF calculated surfaces what is 
reflected in lower zero point vibrational energy values. 
In Table 2 are collected the hydration free energies 
calculated with Langevin dipoles. Reduction of the 
barrier relative to the corresponding in vacuo values is 
due to the zwitterionic nature of the transition state. 
The HF calculated activation free energies togeth-
er with more flexible basis sets in conjunction with the 
LD free energies of hydration are in almost perfect 
agreement with the experiment. The corresponding 
B3LYP barriers are too low. 
 
DISCUSSION 
In this article we studied a chemical reaction between 
the probable ultimate carcinogen styrene-7,8 oxide and 
guanine. The structures of the transition state and reac-
tants, calculated on the B3LYP/6-311++G(d,p) level are 
shown in Figure 1. DNA was truncated to methylated 
guanine, where the sugar moiety is mimicked by the 
methyl group. 
Styrene-7,8-oxide is biologically relevant per se 
and is also a model compound for numerous larger 
ultimate carcinogens, like benzpyrene. DNA was trun-
cated to guanine, the chemically relevant part that enters 
the reaction. The reaction proceeds via mechanism 
common to all epoxy ultimate carcinogens. 
Effects of solvation were calculated using the 
Langevin dipoles. 
We demonstrated that Hartree-Fock calculated 
barrier when combined with Langevin dipoles method 
for calculation of hydration free energies gives very 
reasonable agreement with the experimental free energy 
of activation. On the other hand B3LYP calculations 
predict too low activation free energy in conjunction 
with LD solvation model. Disagreement between the 
experimental and calculated activation free energies can 
be also explained by considering only part of DNA 
(guanine) and not treating water and counterions in 
atomic details. 
Guengerich and coworkers demonstrated that al-
kylation of oligonucleotide guanine proceeds slower 
than alkylation of DNA guanine (the difference in free 
energy is 1−2 kcal mol−1),28 what can be attributed to 
praeorganized electrostatics ineherent to DNA. The 
catalytic effect is considerably smaller than in the case 
of enzymes.29 To properly understand these effects one 
has to proceed with advanced quantum chemical calcu-
lations and QM/MM in conjunction with free energy 
calculations. Methodology is developed and ready to be 
used.29−36 
Carcinogenesis is a complex biomolecular process 
involving many chemical reactions.1 It is therefore a 
major challenge to understand and model those reac-
tions. We have impression that the B3LYP functional 
systematically underestimates the reaction barrier. A 
possible explanation is that there were no epoxy species 
in the parametrization set. Due to the size of the system 
we did not manage to perform post Hartree-Fock calcu-
lations what remains a challenge for the future. Se-
miempirical method PM3 performed surprisingly well 
for this system. 
All in all, we found very good agreement between 
the experimental and calculated free energy of activa-
tion for alkylation of guanine by styrene-7,8-oxide by 
combination of Hartree-Fock calculation using flexible 
enough basis sets and Langevin dipoles calculation of 
hydration free energies. Carcinogenicity is a very com-
plicated process. Carcinogenic compounds can be either 
genotoxic or non-genotoxic. The first step for inducing 
genotoxic cancerogenicity is the alteration of the cellu-
lar DNA by the reactive form of carcinogen. This initial 
reaction leads to translocation and amplification of 
specific genes (protooncogenes), which translate into 
transformation from normal to altered cell. The altered 
cell may remain dormant or under specific circums-
tances may proliferate into praeneoplastic and ultimate-
ly progress to neoplastic cell. 
Beside rate constant for a chemical reaction be-
tween the ultimate carcinogen and DNA are important 
also the reactions of the former with water, proteins and 
the ultimate carcinogen scavengers such as polyphenols. 
 
Figure 1. The structures of the reactants (a) and the transition
state (b), calculated on the B3LYP/6-311++G(d,p) level for
alkylation of guanine with styrene-7,8-oxide. Methyl group of
guanine represents sugar moiety. 
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Moreover, pharmacodynamics of the ultimate carcino-
gens including above threshold carcinogen level as well 
as contact time of the ultimate carcinogen with target 
organs are also a very important factors for carcinoge-
nicity. Ultimately, we expect that only a complex com-
puter simulation of pharmacodynamics of carcinogens 
where reactive steps will be included will yield a meas-
ure for carcinogenicity and will contribute toward un-
derstanding, prevention and treatment of cancer.1,37,38 
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SAŽETAK 
Kancerogenost stiren oxida: proračun kemijske reaktivnosti 
Mojca Kržana i Janez Mavrib 
aInstitute of Pharmacology and Experimental Toxicology, Faculty of Medicine, 
 University of Ljubljana, Slovenia 
bNational Institute of Chemistry, Hajdrihova 19, SI-1001 Ljubljana, POB 660, Slovenia 
U ovom radu su opisani računi slobodne energije aktivacije za kemijsku reakciju između stiren-7,8-oksida i DNK, 
posebice gvanina na položaju N7. Računi su provedeni sa Hartree-Fock i DFT metodama uz korištenje fleksibilnih 
osnovnih skupova. Efekti solvatacije su razmatrani korištenjem Langevin dipoles metode. Izračunate slobodne 
energije aktivacije su u dobrom slaganju sa eksperimentalnom vrijednoću od 26.52 kcal mol−1. 
